KEN CHEN to Humans
This is a "connection" page, showing publications KEN CHEN has written about Humans.
Connection Strength
0.126
-
Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem. 2015 Mar; 61(3):544-53.
Score: 0.010
-
Towards accurate characterization of clonal heterogeneity based on structural variation. BMC Bioinformatics. 2014 Sep 08; 15:299.
Score: 0.010
-
TIGRA: a targeted iterative graph routing assembler for breakpoint assembly. Genome Res. 2014 Feb; 24(2):310-7.
Score: 0.009
-
CanDrA: cancer-specific driver missense mutation annotation with optimized features. PLoS One. 2013; 8(10):e77945.
Score: 0.009
-
BreakTrans: uncovering the genomic architecture of gene fusions. Genome Biol. 2013 Aug 23; 14(8):R87.
Score: 0.009
-
BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data. Bioinformatics. 2012 Jul 15; 28(14):1923-4.
Score: 0.008
-
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods. 2009 Sep; 6(9):677-81.
Score: 0.007
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23; 455(7216):1061-8.
Score: 0.007
-
PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. Genome Res. 2007 May; 17(5):659-66.
Score: 0.006
-
A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.003
-
Functional consequence of the MET-T1010I polymorphism in breast cancer. Oncotarget. 2015 Feb 20; 6(5):2604-14.
Score: 0.003
-
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett. 2015 Feb 01; 357(1):179-185.
Score: 0.002
-
Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014 Aug 14; 512(7513):155-60.
Score: 0.002
-
Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps. Discov Med. 2014 Feb; 17(92):101-14.
Score: 0.002
-
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 05 30; 368(22):2059-74.
Score: 0.002
-
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012 Sep 14; 150(6):1121-34.
Score: 0.002
-
The origin and evolution of mutations in acute myeloid leukemia. Cell. 2012 Jul 20; 150(2):264-78.
Score: 0.002
-
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Jun 10; 486(7403):353-60.
Score: 0.002
-
Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012 Mar 22; 366(12):1090-8.
Score: 0.002
-
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012 Jan 11; 481(7382):506-10.
Score: 0.002
-
Massively parallel sequencing approaches for characterization of structural variation. Methods Mol Biol. 2012; 838:369-84.
Score: 0.002
-
SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics. 2012 Feb 01; 28(3):311-7.
Score: 0.002
-
CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods. 2011 Jun 12; 8(8):652-4.
Score: 0.002
-
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA. 2011 Apr 20; 305(15):1568-76.
Score: 0.002
-
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA. 2011 Apr 20; 305(15):1577-84.
Score: 0.002
-
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. J Clin Invest. 2011 Apr; 121(4):1445-55.
Score: 0.002
-
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010 Apr 15; 464(7291):999-1005.
Score: 0.002
-
CMDS: a population-based method for identifying recurrent DNA copy number aberrations in cancer from high-resolution data. Bioinformatics. 2010 Feb 15; 26(4):464-9.
Score: 0.002
-
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med. 2009 Sep 10; 361(11):1058-66.
Score: 0.002
-
VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics. 2009 Sep 01; 25(17):2283-5.
Score: 0.002
-
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008 Nov 06; 456(7218):66-72.
Score: 0.002
-
Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.
Score: 0.002
-
Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain. PLoS Comput Biol. 2006 Jan; 2(1):e1.
Score: 0.001
-
Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis. J Proteome Res. 2006 Jan; 5(1):32-43.
Score: 0.001